CLAL BIOTECHNOLOGY Fundamental Relationships

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 30px;;'>CLA</div>
The Drivers Module shows relationships between CLAL BIOTECHNOLOGY's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of CLAL BIOTECHNOLOGY over time as well as its relative position and ranking within its peers. Continue to Trending Equities.

CLAL BIOTECHNOLOGY Total Debt vs. Market Capitalization Fundamental Analysis

CLAL BIOTECHNOLOGY is number one stock in market capitalization category among related companies. It is the top company in total debt category among related companies . The ratio of Market Capitalization to Total Debt for CLAL BIOTECHNOLOGY is about  557.96 
CLAL BIOTECHNOLOGY is number one stock in market capitalization category among related companies. Market capitalization of Biotechnology industry is currently estimated at about 58.34 Billion. CLAL BIOTECHNOLOGY totals roughly 29.17 Billion in market capitalization claiming about 50% of stocks in Biotechnology industry.
Capitalization  Valuation  Workforce  Revenue  Total debt
Market Capitalization is total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
CLAL BIOTECHNOLOGY 
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
=
29.17 B
In most publications or references market cap is broken down into the mega cap, large cap, mid cap, small cap, micro cap, and nano cap. Market Cap is a measurement of business as total market value of all of outstanding shares at a given time, and can be used to compare different companies based on their size.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principle payments will eventually prevent the firm from borrow excessively.
CLAL BIOTECHNOLOGY 
Total Debt 
 = 
Bonds 
+  
Notes 
=
52.28 M
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
CLAL BIOTECHNOLOGY is the top company in total debt category among related companies. Total debt of Biotechnology industry is currently estimated at about 104.56 Million. CLAL BIOTECHNOLOGY totals roughly 52.28 Million in total debt claiming about 50% of stocks in Biotechnology industry.
Total debt  Workforce  Revenue  Valuation  Capitalization

CLAL BIOTECHNOLOGY Fundamental Comparison